Navigation Links
Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH
Date:12/9/2008

CHESHIRE, Conn., Dec. 9 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), was observed by investigators to reduce blood measures associated with undiagnosed blood clots and inflammation in patients with PNH.

A separate study found that Soliris was observed to reduce indicators of pulmonary artery hypertension (PAH) in patients with paroxysmal nocturnal hemoglobinuria (PNH), according to a new analysis of clinical trial data. Both sets of data were presented in oral sessions yesterday at the 50th Annual Meeting of the American Society of Hematology.

"The common, severe and progressive clinical consequences of PNH are becoming more apparent as researchers gain more experience and basic knowledge with regard to this disease," said Leonard Bell, M.D., Chief Executive Officer of Alexion.

Blood Markers of Thrombin Generation and Inflammation

Research titled "Eculizumab Therapy Results in Rapid and Sustained Decreases in Markers of Thrombin Generation and Inflammation in Patients with PNH" was presented yesterday in an oral session at the ASH annual meeting by Ilene Ceil Weitz, M.D., Assistant Clinical Professor of Medicine, Jane Anne Nohl Division of Hematology, Keck School of Medicine of the University of Southern California.

Recently published research showed that patients with PNH were observed to have 92 percent fewer blood clots (thromboses) during treatment with Soliris (1) compared to the period of time prior to Soliris treatment. To better understand the mechanism for this observed reduction, researchers used highly sensitive laboratory tests to track levels of blood markers in order to determine the effect of Soliris on markers of thrombin generation and inflammation among ei
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
2. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
3. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
6. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
7. Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
8. Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
9. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
10. NIST studies how new helium ion microscope measures up
11. SpectraCell Laboratories Now Measures Vitamin C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 Results from a Phase ... and its ability to reduce the size of melanoma ... published in the Journal of Clinical Oncology. , ... IIIB, IIIC and IV melanoma, a potentially fatal form ... was to evaluate the safety and efficacy of the ...
(Date:5/28/2015)... DUBLIN , May 28, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/7k46bt/therapeutic_drug ) has announced the addition of ... Monitoring - Technologies, Markets, and Companies" ... http://photos.prnewswire.com/prnh/20130307/600769) , This report deals ... specialty, aimed at improving patient care by ...
(Date:5/28/2015)... Research and Markets( http://www.researchandmarkets.com/research/l9dqwt/animal_genetics ) has announced the addition ... Testing services - Global Forecast to 2020" report ... market is estimated to be worth around $2.5 billion ... during the forecast period of 2014 to 2020 ... protein consumption, increasing adoption of advanced genetic technologies for ...
(Date:5/28/2015)... , May 28, 2015 Celsion Corporation (the ... has received commitments from two institutional healthcare investors to ... Company,s common stock in an at-the-market registered direct offering ... common stock. The Company entered into a ... the Company agreed to sell an aggregate of 3,000,000 ...
Breaking Biology Technology:Study Published in Journal of Clinical Oncology Reports Talimogene Laherparepvec Improvesdurable Responses in Patients with Advanced Melanoma 2Global Therapeutic Drug Monitoring Market 2015-2024 2Global Animal Genetics (Canine, Equine, Poultry, Porcine, Bovine, and Genetic Material) Market 2015 - Global Forecast to 2020 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 3
... In" Program to Launch at the Annual Oncology Nursing Society ... AMGN ) and ONS Edge , a subsidiary ... will partner alongside celebrity make-up artist and cancer survivor Jan ... Cancer From the Outside In . The initiative is aimed ...
... Tigris Pharmaceuticals, Inc., a privately held drug development ... novel molecule, AFP-464, during the recent AACR 100th Annual ... significant advancement in the treatment of Triple Negative Breast ... breast cancer," stated Edmundo Muniz, M.D., Ph.D., President and ...
... convertible debentures of Victhom , to be completed ... /PRNewswire-FirstCall/ - Victhom Human Bionics Inc. ("Victhom", TSX: ... announced today the execution on April 29, 2009 ... venture to develop and commercialize products currently being ...
Cached Biology Technology:Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 2Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 3Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 4Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 5Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 6Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 2Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 3Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 2Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 5
(Date:4/27/2015)... -- For more than four decades, AUVSI,s Unmanned Systems ... worldwide event for the unmanned land, sea, and air ... any local, national, or trade news organization interested in ... current applications of unmanned technologies. The conference will explore ... industry, and how it will soon impact the lives ...
(Date:4/21/2015)... -- High crime rate, increasing government ... control systems market in Saudi Arabia ... report by TechSci Research " Saudi Arabia Access Control Systems Market ... market in Saudi Arabia is ... systems market in the Kingdom is growing at a ...
(Date:4/17/2015)... , April 17, 2015 ... concerns, and technological advancement to drive biometric systems ... until 2020   According to a ... Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... to register growth at CAGR of over 22% ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... Mich. Michigan State University veterinarians are taking part ... cancers in dogs, research that could offer new insight ... the human form of the disease. The Canine ... clinicians, nonprofit institutions, universities and industry members will ...
... the Philippines, which aims to develop a new, higher-yielding rice plant ... being led by an academic at the University of Sheffield. ... a dollar a day and nearly one billion live in hunger. ... increase by about 50 per cent and water scarcity will grow. ...
... , NEW YORK, NY June 21, 2010 NYU ... award from the Empire State Stem Cell Boards New York ... be used to expand the NYU RNAi Core Facility and ... School of Medicine. The purpose of the collaboration is ...
Cached Biology News:From bark to bedside: Study looks at canine cancer genes, human health impact 2Rice yields researched to tackle food security issues 2Rice yields researched to tackle food security issues 3NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research 2